Hamilton G - Search Results

1

Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells.

Plangger A, Rath B, Hochmair M, Funovics M, Hamilton G. Plangger A, et al. Among authors: hamilton g. Transl Oncol. 2021 Dec;14(12):101230. doi: 10.1016/j.tranon.2021.101230. Epub 2021 Sep 28. Transl Oncol. 2021. PMID: 34598083 Free PMC article.

2

Synergism of cyclin-dependent kinase inhibitors with camptothecin derivatives in small cell lung cancer cell lines.

Hamilton G, Klameth L, Rath B, Thalhammer T. Hamilton G, et al. Molecules. 2014 Feb 17;19(2):2077-88. doi: 10.3390/molecules19022077. Molecules. 2014. PMID: 24549232 Free PMC article.

3

A short update on cancer chemoresistance.

Hamilton G, Rath B. Hamilton G, et al. Wien Med Wochenschr. 2014 Nov;164(21-22):456-60. doi: 10.1007/s10354-014-0311-z. Epub 2014 Sep 24. Wien Med Wochenschr. 2014. PMID: 25249024 Review.

4

Pharmacokinetics of crizotinib in NSCLC patients.

Hamilton G, Rath B, Burghuber O. Hamilton G, et al. Expert Opin Drug Metab Toxicol. 2015 May;11(5):835-42. doi: 10.1517/17425255.2015.1021685. Epub 2015 Mar 3. Expert Opin Drug Metab Toxicol. 2015. PMID: 25732197 Review.

5

Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells.

Hamilton G, Rath B, Burghuber O. Hamilton G, et al. Transl Lung Cancer Res. 2015 Jun;4(3):287-91. doi: 10.3978/j.issn.2218-6751.2015.04.04. Transl Lung Cancer Res. 2015. PMID: 26207216 Free PMC article. Review.

6

Smoking, inflammation and small cell lung cancer: recent developments.

Hamilton G, Rath B. Hamilton G, et al. Wien Med Wochenschr. 2015 Oct;165(19-20):379-86. doi: 10.1007/s10354-015-0381-6. Epub 2015 Aug 20. Wien Med Wochenschr. 2015. PMID: 26289596 Review.

7

Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer.

Hamilton G, Rath B, Klameth L, Hochmair M. Hamilton G, et al. Oncoscience. 2015 Jul 31;2(7):629-34. doi: 10.18632/oncoscience.179. eCollection 2015. Oncoscience. 2015. PMID: 26328272 Free PMC article.

8

How to target small cell lung cancer.

Hamilton G, Rath B, Ulsperger E. Hamilton G, et al. Oncoscience. 2015 Aug 21;2(8):684-92. doi: 10.18632/oncoscience.212. eCollection 2015. Oncoscience. 2015. PMID: 26425658 Free PMC article.

9

Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.

Hamilton G, Hochmair M, Rath B, Klameth L, Zeillinger R. Hamilton G, et al. Cell Adh Migr. 2016 Jul 3;10(4):360-7. doi: 10.1080/19336918.2016.1155019. Epub 2016 Feb 26. Cell Adh Migr. 2016. PMID: 26919626 Free PMC article.

10

Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells.

Hamilton G, Rath B, Holzer S, Hochmair M. Hamilton G, et al. Transl Lung Cancer Res. 2016 Feb;5(1):71-7. doi: 10.3978/j.issn.2218-6751.2015.12.12. Transl Lung Cancer Res. 2016. PMID: 26958494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,670 results

Search Page